Home Home
中文 English

NEWS

  1. Home
  2. News
  3. Forecyte Bio and Cytiva team up to accelerate development and manufacturing of cell and gene therapies

Forecyte Bio and Cytiva team up to accelerate development and manufacturing of cell and gene therapies

  • Categories:News
  • Author:BioPharmaAPAC
  • Origin:https://biopharmaapac.com/news/18/1927/forecyte-bio-and-cytiva-team-up-to-accelerate-development-and-manufacturing-of-cell-and-gene-therapies.html
  • Time of issue:2022-08-30 09:53
  • Views:

Through the installation of Cytiva’s FlexFactory facilities, Forecyte Bio gains access to industry-leading GMP production platformsto manufacture viral vectors and plasmid DNA for the China and United States markets

Keyword:

Previous: Golden Autumn Double Ringing
Next: Forecyte Bio Showed up at ATMP2022

latest information

2023-04-12
Forecyte Bio, a CGT CDMO, Hosted a Grand Opening for Its Brand-New GMP Facility in Shanghai, Just Two Months After Its Sister Site in the United States
2023-01-20
Forecyte Bio's Grand Opening of the CGMP Facility in Maryland
2022-11-18
The first day of the CIIE signed a strategic cooperation agreement
2022-11-18
Forecyte Bio was listed in the "Top 10 Most Growing Innovative CXO Companies" in China”
2022-11-07
进博会首日签约 | 源健优科与赛默飞达成战略合作
2022-10-24
Focusing on the U.S. West Coast, Forecyte Bio successfully participated in the Meeting on the Mesa
2022-10-24
Golden Autumn Double Ringing--the first stop of Forecyte Bio in Asia was successful
2022-10-12
Focusing on the U.S. West Coast, Forecyte will attend the Cell & Gene Meeting on The Mesa

Contact

Forecyte Bio Limited

US:

7495 New Horizon Way, Suite 130-150, Frederick，MD 21703
Tel.: +1 215-589-3593

China:

177 Yiwei Road, Pilot free trade zone, Shanghai, China
Tel.：+86 21 80438700
E-mail：info@forecytebio.com

+1 215-589-3593
info@forecytebio.com
  • 微信公众号

    微信二维码